416 related articles for article (PubMed ID: 34096197)
21. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
22. Progress of delivery methods for CRISPR-Cas9.
Yang W; Yan J; Zhuang P; Ding T; Chen Y; Zhang Y; Zhang H; Cui W
Expert Opin Drug Deliv; 2022 Aug; 19(8):913-926. PubMed ID: 35818792
[TBL] [Abstract][Full Text] [Related]
23. Microfluidic Cell Stretching for Highly Effective Gene Delivery into Hard-to-Transfect Primary Cells.
Hur J; Park I; Lim KM; Doh J; Cho SG; Chung AJ
ACS Nano; 2020 Nov; 14(11):15094-15106. PubMed ID: 33034446
[TBL] [Abstract][Full Text] [Related]
24. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
25. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
26. Nanoinjection: A Platform for Innovation in Ex Vivo Cell Engineering.
Chen Y; Shokouhi AR; Voelcker NH; Elnathan R
Acc Chem Res; 2024 Jun; 57(12):1722-1735. PubMed ID: 38819691
[TBL] [Abstract][Full Text] [Related]
27. RNA and CRISPR Interferences: Past, Present, and Future Perspectives.
Sioud M
Methods Mol Biol; 2020; 2115():1-22. PubMed ID: 32006392
[TBL] [Abstract][Full Text] [Related]
28. Viral Delivery Systems for CRISPR.
Xu CL; Ruan MZC; Mahajan VB; Tsang SH
Viruses; 2019 Jan; 11(1):. PubMed ID: 30621179
[TBL] [Abstract][Full Text] [Related]
29. Numerical optimization of microfluidic vortex shedding for genome editing T cells with Cas9.
Jarrell JA; Sytsma BJ; Wilson LH; Pan FL; Lau KHWJ; Kirby GTS; Lievano AA; Pawell RS
Sci Rep; 2021 Jun; 11(1):11818. PubMed ID: 34083685
[TBL] [Abstract][Full Text] [Related]
30. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
31. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
32. Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing.
Tang H; Zhao X; Jiang X
Adv Drug Deliv Rev; 2021 Jan; 168():55-78. PubMed ID: 32147450
[TBL] [Abstract][Full Text] [Related]
33. Engineered CRISPR Systems for Next Generation Gene Therapies.
Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
[TBL] [Abstract][Full Text] [Related]
34. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
Musunuru K
J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
36. Pre-clinical non-viral vectors exploited for
Rouatbi N; McGlynn T; Al-Jamal KT
Biomater Sci; 2022 Jun; 10(13):3410-3432. PubMed ID: 35604372
[TBL] [Abstract][Full Text] [Related]
37. Synthetic nanoparticles for the delivery of CRISPR/Cas9 gene editing system: classification and biomedical applications.
Zheng Q; Wang W; Zhou Y; Mo J; Chang X; Zha Z; Zha L
Biomater Sci; 2023 Aug; 11(16):5361-5389. PubMed ID: 37381725
[TBL] [Abstract][Full Text] [Related]
38. Clustered Regularly Interspaced short palindromic repeats-Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives.
Xie Y; Li H; Chen F; Udayakumar S; Arora K; Chen H; Lan Y; Hu Q; Zhou X; Guo X; Xiu L; Yin K
Adv Sci (Weinh); 2022 Dec; 9(34):e2204172. PubMed ID: 36257813
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.
Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK
AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic gene editing: delivery and regulatory perspectives.
Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
